ClassID:

95141

C07D319/16 - CPC Classification

Classification description:

Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms 1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Sub-classes:
Recent Application in this class:
#1
20260035353
2026-02-05

PHENOL DERIVATIVES FOR USE AS ANTIMICROBIAL, ANTIBACTERIAL, BACTERICIDE

#2
20250059153
2025-02-20

BICYCLIC QUINONES, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS

#3
20240383870
2024-11-21

HETEROCYCLIC ALDEHYDE TRAPPING COMPOUNDS AND USES THEREOF

#4
20240101510
2024-03-28

APYRASE INHIBITORS

#5
20230348412
2023-11-02

METHOD FOR PREPARING GLP-1 RECEPTOR AGONIST

#6
20230172903
2023-06-08

INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE

#7
20230133581
2023-05-04

Novel 3,5-Diaminobenzoic Acid Compound, and PIN1 Inhibitor and Therapeutic Agent for Inflammatory Diseases Using Same

#8
20230053726
2023-02-23

γ-diketones as Wnt/β-catenin signaling pathway activators

#9
20220388975
2022-12-08

Sulfonamide benzamide derivative and preparation method and application thereof

#10
20220315525
2022-10-06

AROMATIC VINYL OR AROMATIC ETHYL DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION

#11
20220281835
2022-09-08

PHENOL DERIVATIVES FOR USE AS ANTIMICROBIAL, ANTIBACTERIAL, BACTERICIDE

#12
20210393590
2021-12-23

INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE

#13
20210369672
2021-12-02

INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE

#14
20210353604
2021-11-18

ß- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ ß -CATENIN SIGNALING PATHWAY ACTIVATORS

#15
20210061755
2021-03-04

Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application

#16
20200223834
2020-07-16

Gamma-diketones as wnt/β-catenin signaling pathway activators

#17
20200181115
2020-06-11

Method for preparing 2-hydroxyl-4-(2, 3-disubstituted benzyloxy)-5-substituted benzaldehyde derivative

#18
20200140382
2020-05-07

Substituted sulfoximine compounds

#19
20200121663
2020-04-23

B- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ B -CATENIN SIGNALING PATHWAY ACTIVATORS

#20
20200087281
2020-03-19

Fused bicyclic compounds, compositions and applications thereof

#21
20200087248
2020-03-19

Fluoroallylamine Derivative And Use Thereof

#22
20200055819
2020-02-20

Nicotinyl alcohol ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof

#23
20190276398
2019-09-12

N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors

#24
20190241531
2019-08-08

Benzyl phenyl ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof

#25
20190233405
2019-08-01

Phenylate derivative, preparation method therefor, and pharmaceutical composition and uses thereof

#26
20190055227
2019-02-21

γ-diketones as Wnt/β-catenin signaling pathway activators

#27
20190047977
2019-02-14

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

#28
20180333400
2018-11-22

β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activators

#29
20180289664
2018-10-11

Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors

#30
20180230092
2018-08-16

NOVEL ANTIVIRAL AGENTS AGAINST HBV INFECTION

#31
20170260176
2017-09-14

γ-diketones as Wnt/β-catenin signaling pathway activators

#32
20170247320
2017-08-31

Amino-phenyl-sulfonyl-acetate derivatives and use thereof

#33
20170152213
2017-06-01

AMINE-CONTAINING LIPIDOIDS AND USES THEREOF

#34
20160280643
2016-09-29

N-(1-hydroxy-3-(pyrrolidinyl)propan-2-yl)pyrrolidine-3-carboxamide derivatives as glucosylceramide synthase inhibitors

#35
20160272611
2016-09-22

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

#36
20160166542
2016-06-16

Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase

#37
20160024004
2016-01-28

Antiviral agents against HBV infection

#38
20150329518
2015-11-19

Therapeutic prostaglandin receptor agonists

#39
20150315126
2015-11-05

Cycloproplyamine derivatives useful as inhibitors of histone demethylases KDM1A

#40
20150299174
2015-10-22

β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activators

#41
20150299157
2015-10-22

β- and γ-diketones and γ-hydroxyketones as / β-catenin signaling pathway activators

#42
20150031663
2015-01-29

PHTHALANILATE COMPOUNDS AND METHODS OF USE

#43
20140336174
2014-11-13

Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease

#44
20140249306
2014-09-04

HIV replication inhibitor

#45
20140243349
2014-08-28

γ-diketones as WNT/β-catenin signaling pathway activators

#46
20140161830
2014-06-12

Amine-containing lipidoids and uses thereof

#47
20140073595
2014-03-13

Aromatic amides as potentiators of bioefficacy of anti-infective drugs

#48
20130331396
2013-12-12

Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase

#49
20130281486
2013-10-24

2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases

#50
20130225573
2013-08-29

Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease

#51
20130137743
2013-05-30

Amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase

#52
20120232150
2012-09-13

Phthalanilate compounds and methods of use

#53
20120046320
2012-02-23

β- and γ-diketones and γ-hydroxyketones as /β-catenin signaling pathway activators

#54
20120035210
2012-02-09

2,3-DIHYDROBENZO(1,4) DIOXIN-2-YLMETHYL DERIVATIVES AS ALPHA2C ANTAGONISTS FOR USE IN THE TREATMENT OF PERIPHERIC AND CENTRAL NERVOUS SYSTEME DISEASES

#55
20110166134
2011-07-07

Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease

#56
20110105462
2011-05-05

MODULATORS OF DOPAMINE NEUROTRANSMISSION

#57
20110105461
2011-05-05

Modulators of dopamine neurotransmission

#58
20100216836
2010-08-26

2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous systeme diseases

#59
20100160327
2010-06-24

Modified malonate derivatives

#60
20100004261
2010-01-07

Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase

#61
20090203696
2009-08-13

Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics

#62
20090105241
2009-04-23

Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives

#63
20070270485
2007-11-22

Byrostatin analogues, synthetic methods and uses

#64
20070270436
2007-11-22

NOVEL AMINO- AND IMINO-ALKYLPIPERAZINES

#65
20070259888
2007-11-08

Novel Compounds

#66
20070004645
2007-01-04

Aromatic amides as potentiators of bioefficacy of anti-infective drugs

#67
20060241119
2006-10-26

Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives

#68
20060173184
2006-08-03

Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase

#69
20050282821
2005-12-22

Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives